These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9334143)

  • 1. [Pefloxacin mesylate--clinical effectiveness in various forms of infectious-inflammatory diseases].
    Pozdniakova VP; Nestetrova LIa; Smirnova LB; Iakovlev VP; Blatun LA; Koshil' OI; Fedorov SM; Bakalova LA; Strachunskiĭ LS; Kurmanova KB
    Antibiot Khimioter; 1997; 42(7):20-3. PubMed ID: 9334143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic basis for the use of pefloxacin in severe forms of infectious-inflammatory diseases].
    Navashin PS; Smirnova LB
    Antibiot Khimioter; 1998; 43(12):30-8. PubMed ID: 10079873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of pefloxacin in the treatment of patients with purulent wounds of soft tissues].
    Blatun LA; Puchkova LS; Navashin PS; Iakovlev VP; Svetykhin AM
    Antibiot Khimioter; 1999; 44(1):20-2. PubMed ID: 10095920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of pefloxacin in brucellosis].
    Kurmanova KB; Kkhamfyang S; Iudin SM
    Antibiot Khimioter; 1995 Jul; 40(7):39-42. PubMed ID: 8645059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effectiveness of pefloxacin (abaktal)in the treatment of inflammatory diseases of the kidneys, urinary tracts and genital organs].
    Lopatkin NA; Darenkov AF; Derevianko II; Perepanova TS; Kotliarova GA; Nosova TA
    Antibiot Khimioter; 1993; 38(2-3):44-9. PubMed ID: 8074566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of pefloxacin in the treatment of infected burn wounds].
    Iakovlev VP; Alekseev AA; Krutikov MG; Grishina IA; Izotova GN
    Antibiot Khimioter; 1996 Jun; 41(6):39-43. PubMed ID: 9054328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pefloxacin in the treatment of postoperative sepsis in gynaecology.
    Arowojolu AO; Bakare RA; Oni AA; Ayodele AE; Kayode OO
    Afr J Med Med Sci; 1999; 28(3-4):151-3. PubMed ID: 11205820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Gonzalez JP; Henwood JM
    Drugs; 1989 May; 37(5):628-68. PubMed ID: 2663414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pefloxacin in the treatment of acute severe infections in hospitalized patients. Clinical and bacteriological evaluation.
    Giustina A; Romanelli G; Cravarezza P; Ravizzola G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):668-9. PubMed ID: 16312584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of pefloxacin in the surgical clinic].
    Iakovlev VP; Blatun LA; Khlebnikov EP; Elagina LV; Puchkova LS
    Antibiot Khimioter; 1995 Aug; 40(8):43-5. PubMed ID: 8713438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of pefloxacin in urogenital infections.
    Csata S; Bocskai T
    Ther Hung; 1992; 40(2):72-5. PubMed ID: 1462279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions.
    Yap JC; Wang YT; Chan CC; Ng A; Poh SC
    Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pefloxacin (Abactal): role in modern therapy of bacterial infections].
    Fomina IP; Smirnova LB
    Antibiot Khimioter; 2000; 45(8):42-7. PubMed ID: 10989724
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with pefloxacin in the therapy of typhoid fever.
    Cristiano P; Morelli G; Briante V; Iovene MR; Simioli F; Altucci P
    Infection; 1989; 17(2):86-7. PubMed ID: 2714862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pefloxacin versus chloramphenicol in the therapy of typhoid fever.
    Cristiano P; Imparato L; Carpinelli C; Lauria F; Iovene MR; Corrado MF; Maio P; Imperatore C
    Infection; 1995; 23(2):103-6. PubMed ID: 7622257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pefloxacin in the treatment of septicemia, purulent meningitis and salmonellosis].
    Dordević D; Kaplan M; Cengić D; Vranić B; Dimitrijević K
    Med Arh; 1989; 43(4-6):207-10. PubMed ID: 2640275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.
    Asli B; Bienvenu B; Cordoliani F; Brouet JC; Uzunhan Y; Arnulf B; Malphettes M; Rybojad M; Fermand JP
    Arch Dermatol; 2007 Aug; 143(8):1046-50. PubMed ID: 17709664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections.
    Vanderdonckt J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():111-6. PubMed ID: 2258338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pefloxacin in the treatment of CAPD peritonitis.
    Tan HW; Kon SP; Chua CT; Ngeow NF
    Med J Malaysia; 1992 Jun; 47(2):128-33. PubMed ID: 1494333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.